Clearing obstacles on the road to recovery

Leuven research team identifies a cellular switch that blocks spinal cord circuit reorganization after injury and suggests a way to reverse it

6 May 2022

A research team led by Aya Takeoka (NERF, empowered by imec, KU Leuven, and VIB) has uncovered that specific types of nerve cells in the spinal cord undergo a switch after injury. This switch turns off communication with motor neurons that stimulate muscles and, therefore movement. Importantly, research in mice suggests that reversing this switch can dramatically improve functional recovery, especially in combination with physical training. The findings offer important insights for rehabilitation strategies for paraplegic patients and are published today in Nature Neuroscience.

Every year, about 10,000 people in Europe get into an accident that injures their spinal cord, leaving many of them with permanent paralysis of (part of) their body. As there currently exists no treatment to regenerate interrupted nerve fibers and repair the damaged spinal cord, 200,000 individuals in the EU live with the consequences of a spinal cord injury.

Prof. Aya Takeoka studies how neuronal circuits regulate movements and potentially help motor recovery after traumatic injury in her lab at Neuro-Electronics Research Flanders (NERF), a Leuven research institute empowered by imec, KU Leuven, and VIB. “There is still a lot we don’t understand about the plasticity of nerve cells, and this knowledge could potentially help patients with spinal cord injury,” Takeoka says.

Switching plasticity on and off

Research has shown that severe spinal cord injury in adults leads to irreversible paralysis below the lesion, while the same lesion occurring just after birth does not impair locomotion. “How the spinal cord can accomplish this in some situations but not always is still a mystery, and one of the central questions for researchers in our field,” explains Takeoka.

Together with her team, she set out to determine how age at injury and activity after injury affect the spinal cord neural circuit’s ability to reorganize itself.

“We found that adult spinal cord injury prompts certain nerve cells in the spinal cord to switch off their normal mode of communication, essentially reversing the signal they pass on to motor neurons, the nerve cells that finally innervate and activate the muscle,” says Hannah Bertels, a PhD student in the Takeoka lab.

Instead of stimulating their target connections, the occurrence of a spinal cord lesion causes these neurons to inhibit their contacts. Importantly, this switch did not occur when the injury happened at a young age.

Spinal cord section highlighting the nerve cells that switch communication mode in bright yellow

Clearing roadblocks

The researchers took it one step further and explored whether intervening in this process could immediately affect the recovery process. Bertels: “We found that if we prevent this switch in communication, the ability to walk after injury indeed improved significantly, especially in combination with locomotor training.”

The reverse was also true: forcing the switch-off of the same nerve cells after injury at a very young age—where it normally does not occur—abolished the remarkable ability of these animals to walk without direct nerve signals from the brain, demonstrating once again that leaving the switch ‘on’ is essential. ​ ​

“Together, these data demonstrate that the dynamic switch of specific spinal cord nerve cells regulates locomotor recovery after spinal cord injury,” says Takeoka. “While the clinical significance of these biological and mechanistic findings has yet to be explored, our results stress the importance of targeting a defined subset of nerve cells, combined with physical therapy, in rehabilitative strategies after spinal cord injury.”

 

Neurotransmitter phenotype switching by spinal excitatory interneurons regulates locomotor recovery after spinal cord injury
Bertels et al. Nature Neuroscience 2022

 

Share

Latest stories

Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be
Website preview
Brain immune cells may help build Alzheimer’s plaques
A new study led by researchers from VIB and KU Leuven shows that immune cells called microglia can actively promote the formation of plaques in Alzheimer’s disease, challenging the long-standing view that these cells serve only as defenders against plaque buildup. The findings were recently published in PNAS.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be